Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Hims & Hers Health, Inc.HIMS · Entity 1878 | Director | August 14, 2026 | August 18, 2026 |
| NETFLIX INCNFLX · Entity 403 | CFO | January 02, 2019 | January 04, 2019 |
| Trade Desk, Inc.TTD · Entity 3752 | Director | May 13, 2025 | May 15, 2025 |
| Wise Group plcWSE · Entity 3428 | Director | May 08, 2026 | May 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Hims & Hers Health, Inc.
Report date August 14, 2026 · Filed August 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 229,808 |
Reported balance
After 2026-08-14 transaction · row 1
1 source rowRow 1 · 2026-08-14 · Exercise / conversion · Acquired 778 · Balance 229,808 F1: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-08-14 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-08-14 · Exercise / conversion · Disposed 778 · Balance 0 F1: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. F2: The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the second quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $23,760 by the grant price of $30.40. The RSUs will vest in full on the Company's next quarterly vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU.
F2: The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the second quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $23,760 by the grant price of $30.40. The RSUs will vest in full on the Company's next quarterly vesting date.
NETFLIX INC
Report date January 02, 2019 · Filed January 04, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $267.66 · Expires 2029-01-02 | Direct | 1,907 |
Reported balance
After 2019-01-02 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2019-01-02 · Grant · Acquired 1,907 · Balance 1,907 |
Trade Desk, Inc.
Report date May 13, 2025 · Filed May 15, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 66,985 |
Ending reported balance
After 2025-05-13 transaction · row 13
13 source rows · reconciled sequenceRow 1 · 2025-05-13 · Exercise / conversion · Acquired 6,990 · Balance 73,975 Row 2 · 2025-05-13 · Exercise / conversion · Acquired 1,390 · Balance 75,365 Row 3 · 2025-05-13 · Exercise / conversion · Acquired 670 · Balance 76,035 Row 4 · 2025-05-13 · Exercise / conversion · Acquired 220 · Balance 76,255 Row 5 · 2025-05-13 · Exercise / conversion · Acquired 6,826 · Balance 83,081 Row 6 · 2025-05-13 · Exercise / conversion · Acquired 1,365 · Balance 84,446 Row 7 · 2025-05-13 · Exercise / conversion · Acquired 655 · Balance 85,101 Row 8 · 2025-05-13 · Exercise / conversion · Acquired 218 · Balance 85,319 Row 9 · 2025-05-13 · Exercise / conversion · Acquired 7,282 · Balance 92,601 Row 10 · 2025-05-13 · Exercise / conversion · Acquired 1,374 · Balance 93,975 Row 11 · 2025-05-13 · Exercise / conversion · Acquired 1,374 · Balance 95,349 Row 12 · 2025-05-13 · Exercise / conversion · Acquired 274 · Balance 95,623 Row 13 · 2025-05-13 · Sale · Disposed 28,638 · Balance 66,985 F1: These sales represent the aggregate shares from the twelve acquisitions reported above. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.88 to $79.92, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $58.46 · Expires 2031-05-27 | Direct | 0 |
Reported balance
After 2025-05-13 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2025-05-13 · Exercise / conversion · Disposed 6,990 · Balance 0 F3: This option was previously reported as covering 699 shares at an exercise price of $584.58 per share, but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021. F4: The option was granted on May 27, 2021. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $58.46 · Expires 2031-05-27 | Direct | 0 |
Reported balance
After 2025-05-13 transaction · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · 2025-05-13 · Exercise / conversion · Disposed 1,390 · Balance 0 F5: This option was previously reported as covering 139 shares at an exercise price of $584.58 per share, but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021. F4: The option was granted on May 27, 2021. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $58.46 · Expires 2031-05-27 | Direct | 0 |
Reported balance
After 2025-05-13 transaction · row 16
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 16 · 2025-05-13 · Exercise / conversion · Disposed 670 · Balance 0 F6: This option was previously reported as covering 67 shares at an exercise price of $584.58 per share, but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021. F7: The option was granted on May 27, 2021. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the audit committee immediately prior to such date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $58.46 · Expires 2031-05-27 | Direct | 0 |
Reported balance
After 2025-05-13 transaction · row 17
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 17 · 2025-05-13 · Exercise / conversion · Disposed 220 · Balance 0 F8: This option was previously reported as covering 22 shares at an exercise price of $584.58 per share, but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021. F9: The option was granted on May 27, 2021. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the compensation committee immediately prior to such date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $49.03 · Expires 2032-05-26 | Direct | 0 |
Reported balance
After 2025-05-13 transaction · row 18
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 18 · 2025-05-13 · Exercise / conversion · Disposed 6,826 · Balance 0 F10: The option was granted on May 26, 2022. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $49.03 · Expires 2032-05-26 | Direct | 0 |
Reported balance
After 2025-05-13 transaction · row 19
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 19 · 2025-05-13 · Exercise / conversion · Disposed 1,365 · Balance 0 F10: The option was granted on May 26, 2022. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $49.03 · Expires 2032-05-26 | Direct | 0 |
Reported balance
After 2025-05-13 transaction · row 20
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 20 · 2025-05-13 · Exercise / conversion · Disposed 655 · Balance 0 F11: The option was granted on May 26, 2022. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the audit committee immediately prior to such date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $49.03 · Expires 2032-05-26 | Direct | 0 |
Reported balance
After 2025-05-13 transaction · row 21
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 21 · 2025-05-13 · Exercise / conversion · Disposed 218 · Balance 0 F12: The option was granted on May 26, 2022. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the compensation committee immediately prior to such date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $66.26 · Expires 2033-05-25 | Direct | 0 |
Reported balance
After 2025-05-13 transaction · row 22
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 22 · 2025-05-13 · Exercise / conversion · Disposed 7,282 · Balance 0 F13: The option was granted on May 25, 2023. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $66.26 · Expires 2033-05-25 | Direct | 0 |
Reported balance
After 2025-05-13 transaction · row 23
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 23 · 2025-05-13 · Exercise / conversion · Disposed 1,374 · Balance 0 F13: The option was granted on May 25, 2023. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $66.26 · Expires 2033-05-25 | Direct | 0 |
Reported balance
After 2025-05-13 transaction · row 24
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 24 · 2025-05-13 · Exercise / conversion · Disposed 1,374 · Balance 0 F14: The option was granted on May 25, 2023. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the audit committee immediately prior to such date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $66.26 · Expires 2033-05-25 | Direct | 0 |
Reported balance
After 2025-05-13 transaction · row 25
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 25 · 2025-05-13 · Exercise / conversion · Disposed 274 · Balance 0 F15: The option was granted on May 25, 2023. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the compensation committee immediately prior to such date. |
Filing footnotes · ownership attribution and instrument terms
F1: These sales represent the aggregate shares from the twelve acquisitions reported above.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.88 to $79.92, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3: This option was previously reported as covering 699 shares at an exercise price of $584.58 per share, but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021.
F4: The option was granted on May 27, 2021. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date.
F5: This option was previously reported as covering 139 shares at an exercise price of $584.58 per share, but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021.
F6: This option was previously reported as covering 67 shares at an exercise price of $584.58 per share, but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021.
F7: The option was granted on May 27, 2021. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the audit committee immediately prior to such date.
F8: This option was previously reported as covering 22 shares at an exercise price of $584.58 per share, but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021.
F9: The option was granted on May 27, 2021. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the compensation committee immediately prior to such date.
F10: The option was granted on May 26, 2022. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date.
F11: The option was granted on May 26, 2022. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the audit committee immediately prior to such date.
F12: The option was granted on May 26, 2022. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the compensation committee immediately prior to such date.
F13: The option was granted on May 25, 2023. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date.
F14: The option was granted on May 25, 2023. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the audit committee immediately prior to such date.
F15: The option was granted on May 25, 2023. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the compensation committee immediately prior to such date.
Wise Group plc
Report date May 08, 2026 · Filed May 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Expires 2029-02-27 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2026-05-08 · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · Balance Not disclosed F2: The initial exercise price for the option award was 0.6192 GBP. In connection with the effectiveness of the Issuer's Scheme of Arrangement on May 8, 2026, the option award was assumed by the Issuer and the exercise price thereof was converted from British pound sterling to U.S. dollars using a mid-market exchange rate on May 8, 2026, which is not yet available as of the time of this initial statement of beneficial ownership of securities. The Reporting Person undertakes to provide in a subsequent statement of changes in beneficial ownership full information regarding the exercise price for the option award following the conversion described above. F1: Fully vested and exercisable. |
Filing footnotes · ownership attribution and instrument terms
F1: Fully vested and exercisable.
F2: The initial exercise price for the option award was 0.6192 GBP. In connection with the effectiveness of the Issuer's Scheme of Arrangement on May 8, 2026, the option award was assumed by the Issuer and the exercise price thereof was converted from British pound sterling to U.S. dollars using a mid-market exchange rate on May 8, 2026, which is not yet available as of the time of this initial statement of beneficial ownership of securities. The Reporting Person undertakes to provide in a subsequent statement of changes in beneficial ownership full information regarding the exercise price for the option award following the conversion described above.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 14, 2026 Filed Aug 18, 2026 21:03 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 778 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-26-000208 · wk-form4_1787087030.xml · derivative · entry 2 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 778 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. F2 · derivative.exercise_date: The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the second quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $23,760 by the grant price of $30.40. The RSUs will vest in full on the Company's next quarterly vesting date. F2 · derivative.expiration_date: The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the second quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $23,760 by the grant price of $30.40. The RSUs will vest in full on the Company's next quarterly vesting date. Read SEC document |
| August 14, 2026 Filed Aug 18, 2026 21:03 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 778 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001773751-26-000208 · wk-form4_1787087030.xml · nonDerivative · entry 1 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 229,808 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Read SEC document |
| August 12, 2026 Filed Aug 14, 2026 20:15 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantRestricted Stock Unit · Derivative | 778 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-26-000185 · wk-form4_1786738522.xml · derivative · entry 2 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 778 Underlying: Class A Common Stock · 778 shares Expires not disclosed F1 · derivative.exercise_price: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. F3 · derivative.exercise_date: The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the second quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $23,760 by the grant price of $30.40. The RSUs will vest in full on the Company's next quarterly vesting date. F3 · derivative.expiration_date: The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the second quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $23,760 by the grant price of $30.40. The RSUs will vest in full on the Company's next quarterly vesting date. Read SEC document |
| August 12, 2026 Filed Aug 14, 2026 20:15 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantRestricted Stock Unit · Derivative | 8,223 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-26-000185 · wk-form4_1786738522.xml · derivative · entry 1 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,223 Underlying: Class A Common Stock · 8,223 shares Expires not disclosed F1 · derivative.exercise_price: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. F2 · derivative.exercise_date: Subject to continuous service, the RSUs will vest in full on the first Company quarterly vesting date to occur after the earlier of (x) the date of the Company's next-occurring annual stockholder meeting or (y) the first anniversary of the grant date of the award. F2 · derivative.expiration_date: Subject to continuous service, the RSUs will vest in full on the first Company quarterly vesting date to occur after the earlier of (x) the date of the Company's next-occurring annual stockholder meeting or (y) the first anniversary of the grant date of the award. Read SEC document |
| June 15, 2026 Filed Jun 15, 2026 21:13 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 957 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-26-000116 · wk-form4_1781558022.xml · derivative · entry 4 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 957 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F2 · derivative.expiration_date: The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer and committee membership fees for the first quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $22,000 by the grant price of $22.98. The RSUs will vest in full on the Company's next quarterly vesting date. Read SEC document |
| June 15, 2026 Filed Jun 15, 2026 21:13 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 957 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001773751-26-000116 · wk-form4_1781558022.xml · nonDerivative · entry 2 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 229,030 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer and committee membership fees for the first quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $22,000 by the grant price of $22.98. The RSUs will vest in full on the Company's next quarterly vesting date. Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 21:13 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 3,656 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-26-000116 · wk-form4_1781558022.xml · derivative · entry 3 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 3,656 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2026 annual meeting of stockholders or (b) June 15, 2026. F1 · derivative.exercise_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2026 annual meeting of stockholders or (b) June 15, 2026. F1 · derivative.expiration_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2026 annual meeting of stockholders or (b) June 15, 2026. Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 21:13 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 3,656 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001773751-26-000116 · wk-form4_1781558022.xml · nonDerivative · entry 1 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 228,073 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2026 annual meeting of stockholders or (b) June 15, 2026. Read SEC document |
| May 26, 2026 Filed May 26, 2026 20:48 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | PurchaseClass A Common Stock | 48,400 | $24.24 | $1,172,974.00 |
DisclosureSEC source: 0001773751-26-000086 · wk-form4_1779828505.xml · nonDerivative · entry 1 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 224,417 F1 · price: Price reported constitutes the average weighted price of shares purchased. Shares were purchased at varying prices in the range of $24.19 - $24.25. The Reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| May 20, 2026 Filed May 22, 2026 20:16 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantRestricted Stock Unit · Derivative | 957 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-26-000082 · wk-form4_1779480961.xml · derivative · entry 1 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 957 Underlying: Class A Common Stock · 957 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F2 · derivative.expiration_date: The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer and committee membership fees for the first quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $22,000 by the grant price of $22.98. The RSUs will vest in full on the Company's next quarterly vesting date. Read SEC document |
| August 06, 2025 Filed Aug 8, 2025 20:20 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantRestricted Stock Unit · Derivative | 3,656 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-25-000271 · wk-form4_1754684405.xml · derivative · entry 1 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,656 Underlying: Class A Common Stock · 3,656 shares Expires not disclosed F1 · derivative.exercise_price: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2026 annual meeting of stockholders or (b) June 15, 2026. F1 · derivative.exercise_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2026 annual meeting of stockholders or (b) June 15, 2026. F1 · derivative.expiration_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2026 annual meeting of stockholders or (b) June 15, 2026. Read SEC document |
| June 12, 2025 Filed Jun 17, 2025 00:38 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 9,935 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-25-000200 · wk-form4_1750120677.xml · derivative · entry 2 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 9,935 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2025 annual meeting of stockholders or (b) June 15, 2025. F1 · derivative.exercise_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2025 annual meeting of stockholders or (b) June 15, 2025. F1 · derivative.expiration_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2025 annual meeting of stockholders or (b) June 15, 2025. Read SEC document |
| June 12, 2025 Filed Jun 17, 2025 00:38 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 9,935 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001773751-25-000200 · wk-form4_1750120677.xml · nonDerivative · entry 1 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 176,017 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2025 annual meeting of stockholders or (b) June 15, 2025. Read SEC document |
| May 13, 2025 Filed May 15, 2025 21:05 UTC | Trade Desk, Inc. TTD · Entity 3752 | Exercise / conversionStock Option (Right to Buy) · Derivative | 274 | $0.00 Strike: $66.26 | $0.00 |
DisclosureSEC source: 0001671933-25-000065 · wk-form4_1747343118.xml · derivative · entry 25 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 274 shares Expires 2033-05-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F15 · derivative.exercise_date: The option was granted on May 25, 2023. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the compensation committee immediately prior to such date. Read SEC document |
| May 13, 2025 Filed May 15, 2025 21:05 UTC | Trade Desk, Inc. TTD · Entity 3752 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,374 | $0.00 Strike: $66.26 | $0.00 |
DisclosureSEC source: 0001671933-25-000065 · wk-form4_1747343118.xml · derivative · entry 24 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 1,374 shares Expires 2033-05-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F14 · derivative.exercise_date: The option was granted on May 25, 2023. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the audit committee immediately prior to such date. Read SEC document |
| May 13, 2025 Filed May 15, 2025 21:05 UTC | Trade Desk, Inc. TTD · Entity 3752 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,374 | $0.00 Strike: $66.26 | $0.00 |
DisclosureSEC source: 0001671933-25-000065 · wk-form4_1747343118.xml · derivative · entry 23 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 1,374 shares Expires 2033-05-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F13 · derivative.exercise_date: The option was granted on May 25, 2023. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date. Read SEC document |
| May 13, 2025 Filed May 15, 2025 21:05 UTC | Trade Desk, Inc. TTD · Entity 3752 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,282 | $0.00 Strike: $66.26 | $0.00 |
DisclosureSEC source: 0001671933-25-000065 · wk-form4_1747343118.xml · derivative · entry 22 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 7,282 shares Expires 2033-05-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F13 · derivative.exercise_date: The option was granted on May 25, 2023. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date. Read SEC document |
| May 13, 2025 Filed May 15, 2025 21:05 UTC | Trade Desk, Inc. TTD · Entity 3752 | Exercise / conversionStock Option (Right to Buy) · Derivative | 218 | $0.00 Strike: $49.03 | $0.00 |
DisclosureSEC source: 0001671933-25-000065 · wk-form4_1747343118.xml · derivative · entry 21 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 218 shares Expires 2032-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: The option was granted on May 26, 2022. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the compensation committee immediately prior to such date. Read SEC document |
| May 13, 2025 Filed May 15, 2025 21:05 UTC | Trade Desk, Inc. TTD · Entity 3752 | Exercise / conversionStock Option (Right to Buy) · Derivative | 655 | $0.00 Strike: $49.03 | $0.00 |
DisclosureSEC source: 0001671933-25-000065 · wk-form4_1747343118.xml · derivative · entry 20 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 655 shares Expires 2032-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: The option was granted on May 26, 2022. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the audit committee immediately prior to such date. Read SEC document |
| May 13, 2025 Filed May 15, 2025 21:05 UTC | Trade Desk, Inc. TTD · Entity 3752 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,365 | $0.00 Strike: $49.03 | $0.00 |
DisclosureSEC source: 0001671933-25-000065 · wk-form4_1747343118.xml · derivative · entry 19 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 1,365 shares Expires 2032-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: The option was granted on May 26, 2022. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date. Read SEC document |
| May 13, 2025 Filed May 15, 2025 21:05 UTC | Trade Desk, Inc. TTD · Entity 3752 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,826 | $0.00 Strike: $49.03 | $0.00 |
DisclosureSEC source: 0001671933-25-000065 · wk-form4_1747343118.xml · derivative · entry 18 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 6,826 shares Expires 2032-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: The option was granted on May 26, 2022. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date. Read SEC document |
| May 13, 2025 Filed May 15, 2025 21:05 UTC | Trade Desk, Inc. TTD · Entity 3752 | Exercise / conversionStock Option (Right to Buy) · Derivative | 220 | $0.00 Strike: $58.46 | $0.00 |
DisclosureSEC source: 0001671933-25-000065 · wk-form4_1747343118.xml · derivative · entry 17 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 220 shares Expires 2031-05-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: This option was previously reported as covering 22 shares at an exercise price of $584.58 per share, but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021. F9 · derivative.exercise_date: The option was granted on May 27, 2021. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the compensation committee immediately prior to such date. Read SEC document |
| May 13, 2025 Filed May 15, 2025 21:05 UTC | Trade Desk, Inc. TTD · Entity 3752 | Exercise / conversionStock Option (Right to Buy) · Derivative | 670 | $0.00 Strike: $58.46 | $0.00 |
DisclosureSEC source: 0001671933-25-000065 · wk-form4_1747343118.xml · derivative · entry 16 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 670 shares Expires 2031-05-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: This option was previously reported as covering 67 shares at an exercise price of $584.58 per share, but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021. F7 · derivative.exercise_date: The option was granted on May 27, 2021. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the audit committee immediately prior to such date. Read SEC document |
| May 13, 2025 Filed May 15, 2025 21:05 UTC | Trade Desk, Inc. TTD · Entity 3752 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,390 | $0.00 Strike: $58.46 | $0.00 |
DisclosureSEC source: 0001671933-25-000065 · wk-form4_1747343118.xml · derivative · entry 15 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 1,390 shares Expires 2031-05-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: This option was previously reported as covering 139 shares at an exercise price of $584.58 per share, but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021. F4 · derivative.exercise_date: The option was granted on May 27, 2021. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date. Read SEC document |
| May 13, 2025 Filed May 15, 2025 21:05 UTC | Trade Desk, Inc. TTD · Entity 3752 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,990 | $0.00 Strike: $58.46 | $0.00 |
DisclosureSEC source: 0001671933-25-000065 · wk-form4_1747343118.xml · derivative · entry 14 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 6,990 shares Expires 2031-05-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: This option was previously reported as covering 699 shares at an exercise price of $584.58 per share, but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021. F4 · derivative.exercise_date: The option was granted on May 27, 2021. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date. Read SEC document |
| May 13, 2025 Filed May 15, 2025 21:05 UTC | Trade Desk, Inc. TTD · Entity 3752 | SaleClass A Common Stock | 28,638 | $79.88 | $2,287,603.44 |
DisclosureSEC source: 0001671933-25-000065 · wk-form4_1747343118.xml · nonDerivative · entry 13 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,985 F1 · shares: These sales represent the aggregate shares from the twelve acquisitions reported above. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.88 to $79.92, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| May 13, 2025 Filed May 15, 2025 21:05 UTC | Trade Desk, Inc. TTD · Entity 3752 | Exercise / conversionClass A Common Stock | 274 | $66.26 | $18,155.24 |
DisclosureSEC source: 0001671933-25-000065 · wk-form4_1747343118.xml · nonDerivative · entry 12 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,623 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 13, 2025 Filed May 15, 2025 21:05 UTC | Trade Desk, Inc. TTD · Entity 3752 | Exercise / conversionClass A Common Stock | 1,374 | $66.26 | $91,041.24 |
DisclosureSEC source: 0001671933-25-000065 · wk-form4_1747343118.xml · nonDerivative · entry 11 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,349 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 13, 2025 Filed May 15, 2025 21:05 UTC | Trade Desk, Inc. TTD · Entity 3752 | Exercise / conversionClass A Common Stock | 1,374 | $66.26 | $91,041.24 |
DisclosureSEC source: 0001671933-25-000065 · wk-form4_1747343118.xml · nonDerivative · entry 10 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,975 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 13, 2025 Filed May 15, 2025 21:05 UTC | Trade Desk, Inc. TTD · Entity 3752 | Exercise / conversionClass A Common Stock | 7,282 | $66.26 | $482,505.32 |
DisclosureSEC source: 0001671933-25-000065 · wk-form4_1747343118.xml · nonDerivative · entry 9 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,601 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 13, 2025 Filed May 15, 2025 21:05 UTC | Trade Desk, Inc. TTD · Entity 3752 | Exercise / conversionClass A Common Stock | 218 | $49.03 | $10,688.54 |
DisclosureSEC source: 0001671933-25-000065 · wk-form4_1747343118.xml · nonDerivative · entry 8 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,319 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 13, 2025 Filed May 15, 2025 21:05 UTC | Trade Desk, Inc. TTD · Entity 3752 | Exercise / conversionClass A Common Stock | 655 | $49.03 | $32,114.65 |
DisclosureSEC source: 0001671933-25-000065 · wk-form4_1747343118.xml · nonDerivative · entry 7 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,101 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 13, 2025 Filed May 15, 2025 21:05 UTC | Trade Desk, Inc. TTD · Entity 3752 | Exercise / conversionClass A Common Stock | 1,365 | $49.03 | $66,925.95 |
DisclosureSEC source: 0001671933-25-000065 · wk-form4_1747343118.xml · nonDerivative · entry 6 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,446 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 13, 2025 Filed May 15, 2025 21:05 UTC | Trade Desk, Inc. TTD · Entity 3752 | Exercise / conversionClass A Common Stock | 6,826 | $49.03 | $334,678.78 |
DisclosureSEC source: 0001671933-25-000065 · wk-form4_1747343118.xml · nonDerivative · entry 5 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,081 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 13, 2025 Filed May 15, 2025 21:05 UTC | Trade Desk, Inc. TTD · Entity 3752 | Exercise / conversionClass A Common Stock | 220 | $58.46 | $12,860.76 |
DisclosureSEC source: 0001671933-25-000065 · wk-form4_1747343118.xml · nonDerivative · entry 4 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,255 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 13, 2025 Filed May 15, 2025 21:05 UTC | Trade Desk, Inc. TTD · Entity 3752 | Exercise / conversionClass A Common Stock | 670 | $58.46 | $39,166.86 |
DisclosureSEC source: 0001671933-25-000065 · wk-form4_1747343118.xml · nonDerivative · entry 3 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,035 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 13, 2025 Filed May 15, 2025 21:05 UTC | Trade Desk, Inc. TTD · Entity 3752 | Exercise / conversionClass A Common Stock | 1,390 | $58.46 | $81,256.62 |
DisclosureSEC source: 0001671933-25-000065 · wk-form4_1747343118.xml · nonDerivative · entry 2 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,365 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 13, 2025 Filed May 15, 2025 21:05 UTC | Trade Desk, Inc. TTD · Entity 3752 | Exercise / conversionClass A Common Stock | 6,990 | $58.46 | $408,621.42 |
DisclosureSEC source: 0001671933-25-000065 · wk-form4_1747343118.xml · nonDerivative · entry 1 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,975 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2024 Filed Dec 18, 2024 00:02 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 18 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000400 · wk-form4_1734480165.xml · derivative · entry 4 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 18 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F2 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). F2 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). Read SEC document |
| December 13, 2024 Filed Dec 18, 2024 00:02 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 894 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000400 · wk-form4_1734480165.xml · derivative · entry 3 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 894 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F2 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). F2 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). Read SEC document |
| December 13, 2024 Filed Dec 18, 2024 00:02 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 9,134 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000400 · wk-form4_1734480165.xml · derivative · entry 2 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 9,134 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F2 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). F2 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). Read SEC document |
| December 13, 2024 Filed Dec 18, 2024 00:02 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 10,046 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001773751-24-000400 · wk-form4_1734480165.xml · nonDerivative · entry 1 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 166,082 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. Read SEC document |
| November 13, 2024 Filed Nov 14, 2024 21:57 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 40,000 | $29.99 | $1,199,584.00 |
DisclosureSEC source: 0001773751-24-000356 · wk-form4_1731621438.xml · nonDerivative · entry 1 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 156,036 F1 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $29.97 - $30.055. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| September 13, 2024 Filed Sep 17, 2024 23:07 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 18 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000298 · wk-form4_1726614434.xml · derivative · entry 4 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18 Underlying: Class A Common Stock · 18 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F2 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). F2 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). Read SEC document |
| September 13, 2024 Filed Sep 17, 2024 23:07 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 893 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000298 · wk-form4_1726614434.xml · derivative · entry 3 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 894 Underlying: Class A Common Stock · 893 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F2 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). F2 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). Read SEC document |
| September 13, 2024 Filed Sep 17, 2024 23:07 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 9,133 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000298 · wk-form4_1726614434.xml · derivative · entry 2 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,134 Underlying: Class A Common Stock · 9,133 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F2 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). F2 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). Read SEC document |
| September 13, 2024 Filed Sep 17, 2024 23:07 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 10,044 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001773751-24-000298 · wk-form4_1726614434.xml · nonDerivative · entry 1 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 196,036 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 20:30 UTC | Trade Desk, Inc. TTD · Entity 3752 | GiftClass A Common Stock | 6,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001671933-24-000098 · wk-form4_1724445050.xml · nonDerivative · entry 1 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,985 F1 · kind: Bona fide gift not for value of Class A Common Stock to a charity. Read SEC document |
| August 07, 2024 Filed Aug 8, 2024 20:24 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantRestricted Stock Unit · Derivative | 9,935 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000269 · wk-form4_1723148689.xml · derivative · entry 1 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,935 Underlying: Class A Common Stock · 9,935 shares Expires not disclosed F1 · derivative.exercise_price: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2025 annual meeting of stockholders or (b) June 15, 2025. F1 · derivative.exercise_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2025 annual meeting of stockholders or (b) June 15, 2025. F1 · derivative.expiration_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2025 annual meeting of stockholders or (b) June 15, 2025. Read SEC document |
| June 14, 2024 Filed Jun 18, 2024 21:27 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 18 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000202 · wk-form4_1718746051.xml · derivative · entry 4 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36 Underlying: Class A Common Stock · 18 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F2 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). F2 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.